Home—Medical Resources

Hospitals organized by city and specialty

Medical Resources

Clinical fields

Areas highlighted for further evaluation

These areas are starting points for hospital-specific evaluation. Suitability, availability, evidence, and expected outcomes must be confirmed for each patient.

CAR-T cell therapyThe world’s largest approved portfolio

By mid-2026, China’s NMPA had approved nine CAR-T products, compared with seven in the United States and six in Europe.
In June 2026, the NMPA approved satri-cel (satricabtagene autoleucel), the world’s first approved CAR-T therapy for a solid tumor, for advanced gastric cancer.
Clinical remission rates exceed 80% in hematologic cancers, with long-term remission and even functional cure possible. Ruijin Hospital in Shanghai was among the world’s first commercial CAR-T centers in 2017.

Cardiovascular surgery & interventionThe world’s largest procedural volume

China completes more than one million PCI (percutaneous coronary intervention) procedures each year, the largest procedural volume in the world.
China’s annual CABG volume ranks among the world’s highest, and Peking University Third Hospital’s robot-assisted total-arterial CABG has attracted international attention.
The PAN Procedure uses ultrasound guidance for cardiac intervention without an incision, radiation, or contrast media. It has treated more than 200,000 patients worldwide and has enabled treatment for older adults, pregnant women, cancer patients, and others traditionally considered ineligible.

Proton & heavy-ion radiotherapyOne of the few countries with end-to-end technology

China-developed synchrotron technology uses a compact-ring design that allows the equipment to be installed directly in hospitals, without requiring patients to transfer between institutions.
A network of proton and heavy-ion centers has been established in Shanghai, Beijing, Lanzhou, Shandong, Guangdong, and other regions.
China is one of the few countries with end-to-end capabilities spanning research and development through clinical application.

Innovative oncology drugs & immunotherapyAbout one-third of the global pipeline

China accounts for approximately one-third of the innovative medicines in development worldwide.
In 2025, the total value of China’s overseas licensing agreements for innovative medicines exceeded US$130 billion.
PD-1/PD-L1 inhibitors, targeted therapies, and genomic-testing-guided precision medicine form an established system. Fudan University Shanghai Cancer Center and Sun Yat-sen University Cancer Center are among the institutions at the global forefront.

Joint replacementWorld-leading volume and strong value

In 2025, China performed more than 1.246 million hip and knee replacement procedures.
Beijing Jishuitan Hospital performs more than 10,000 joint replacements annually, ranking among the world’s highest-volume centers.
U.S. orthopedic surgeons perform about 65 joint replacements per year on average, while leading specialists at Chinese tertiary hospitals perform 200–500. This high procedural volume supports more refined techniques and lower complication rates.

Dental implantsGlobally competitive value and same-day care

China places more than four million dental implants each year, and its large case volume supports mature clinical experience and efficient workflows.
Digital workflows combine CBCT 3D imaging, computer-guided implant placement, and CAD/CAM crowns that can be produced within 24–48 hours.
Immediate implant placement and same-day temporary teeth enable patients to “walk in toothless, walk out with fixed teeth.”

Full-body health screeningLower cost and efficient one-stop screening

For comparable equipment and test items, screening programs can cost less than in North America.
Centralized one-stop programs can reduce waiting, repeat referrals, and repeat appointments, with most items completed in the same area within one day.
Packages can cover multiple tumor markers, multi-site ultrasound, low-dose chest CT, echocardiography, bone density, gastroscopy, and colonoscopy, with options such as brain MRI or coronary CT added when needed.

Aesthetic and reconstructive surgeryShorter booking cycles and extensive revision experience

Costs can be lower than in Europe and North America, with shorter appointment lead times.
China’s large aesthetic-medicine market gives many physicians substantial experience with complex revision procedures, including revision rhinoplasty, revision eyelid surgery, and removal of injected foreign material.
High revision-case volumes can support experience in preserving natural proportions and individual facial characteristics, especially for Asian patients.

Traditional Chinese medicine therapiesEstablished traditions and combinable therapies

Established schools of practice have been passed down with a substantial base of hands-on cases.
One institution may combine acupuncture, tuina, moxibustion, cupping, and gua sha according to the individual’s condition.
Relevant experience includes overuse injuries, chronic pain, lumbar-disc problems associated with prolonged sitting, stiff neck, fascial tension, and postoperative soft-tissue stiffness.

Other areas of strength in Chinese healthcare

Dermatology

Explore specialist assessment for eczema, psoriasis, complex skin lesions, and other skin conditions.

Neurosurgery

Explore surgical assessment for brain tumors and cerebrovascular conditions, along with specialist resources for spine and spinal cord, peripheral nerves, and functional neurosurgery. The specific approach is determined by the hospital.

Thoracic medicine and surgery

Explore assessment of lung, pleural, mediastinal, and chest-wall conditions through relevant specialties.

Urology

Explore specialist options for urinary stones, prostate conditions, and urologic cancers.

Explore hospital resources

01SHANGHAI

Huashan Hospital, Fudan University

Neurology · Neurosurgery · Dermatology · Infectious disease

A strong option for complex neurological, neurosurgical, dermatological, and infectious-disease cases.

Medical Resources

Areas highlighted for further evaluation

CAR-T cell therapyThe world’s largest approved portfolio

Cardiovascular surgery & interventionThe world’s largest procedural volume

Proton & heavy-ion radiotherapyOne of the few countries with end-to-end technology

Innovative oncology drugs & immunotherapyAbout one-third of the global pipeline

Joint replacementWorld-leading volume and strong value

Dental implantsGlobally competitive value and same-day care

Full-body health screeningLower cost and efficient one-stop screening

Aesthetic and reconstructive surgeryShorter booking cycles and extensive revision experience

Traditional Chinese medicine therapiesEstablished traditions and combinable therapies

Other areas of strength in Chinese healthcare

Dermatology

Neurosurgery

Thoracic medicine and surgery

Urology

Filter by area of need

Huashan Hospital, Fudan University

Zhongshan Hospital, Fudan University

Children's Hospital of Fudan University

Ruijin Hospital, Shanghai Jiao Tong University

Renji Hospital, Shanghai Jiao Tong University

Shanghai Sixth People's Hospital

Xinhua Hospital, Shanghai Jiao Tong University

Shanghai General Hospital (IMCC)

Shanghai Children's Medical Center

Shanghai First Maternity and Infant Hospital

International Peace Maternity & Child Health Hospital

Huadong Hospital, Fudan University

Longhua Hospital, Shanghai University of TCM

Shanghai Ninth People's Hospital

Fudan University Shanghai Cancer Center

Obstetrics & Gynecology Hospital of Fudan University

Shanghai Tenth People's Hospital

Shanghai Changzheng Hospital

Shanghai Changhai Hospital

Shanghai East Hospital, Tongji University

Shuguang Hospital, Shanghai University of TCM

Yueyang Hospital of Integrated TCM & Western Medicine

Five factors matter more than a famous name

Case acceptance

Relevant department

Physician’s clinical focus

International service fit

Timing and practical feasibility

Tell us what kind of support you need.